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g-Butyrolactone bacterial hormones regulate anti-
biotic production and morphological differentiation
in Streptomyces species. One g-butyrolactone,
SCB1, has been previously characterized in Strepto-
myces coelicolor. Herewe report the characterization
of two additional g-butyrolactones, named SCB2
(2-[10-hydroxyoctyl]-3-hydroxymethylbutanolide) and
SCB3 (2-[10-hydroxy-60-methyloctyl]-3-hydroxyme-
thylbutanolide), possessing an antibiotic stimulatory
activity. To elucidate the specificity determinants of
these ligands for the receptorprotein,ScbR,30chem-
ically synthesized g-butyrolactone analogs were
tested by utilizing the release of ScbR from DNA
upon binding to a g-butyrolactone, which can be
detectedbykanamycin resistance. Thebutyrolactone
detectionmethoddeveloped here revealed that ScbR
shows preference toward a ligand possessing a 7–10
carbon C-2 side chain, a C-10-b-hydroxyl group, and
aC-60-methyl branch that coincideswithSCB3.More-
over, thismethodwas successfully used to screen for
potential g-butyrolactone producers from commer-
cial-antibiotic-producing Streptomyces.
INTRODUCTION
Small extracellular signaling molecules called g-butyrolactones
are involved in the regulation of antibiotic production and, in
some cases, morphological differentiation in the soil-dwelling
Streptomyces (Takano, 2006). Regarded as bacterial hormones,
the g-butyrolactones are active at nanomolar concentrations
and are thought to diffuse freely in and out of the cell. Twelve
g-butyrolactones, which have a 2,3-di-substituted g-butyrolac-
tone skeleton in common, have been identified to date. These
have been classified into the following three groups based on
their structural differences (Figure 1): (1) A-factor type, possess-
ing a 10-keto group; (2) virginiae butanolide (VB) type, possessingChemistry & Biology 16, 951–a 10-a-hydroxyl group; and (3) IM-2 type, possessing a 10-b-
hydroxyl group (Choi et al., 2003). Early studies in Streptomyces
coelicolor led to the partial elucidation of six g-butyrolactone
compounds (see Figure S1 available online; Anisova et al.,
1984) but no biological function was determined in the produc-
ing strain. Takano et al. (2000) characterized the IM-2-type
compound SCB1 from S. coelicolor that possesses antibiotic
stimulatory activity, but does not have same structure as those
identified by Anisova et al. (1984). In this study, two additional
g-butyrolactones, named SCB2 and SCB3, were successfully
isolated from S. coelicolor and their chemical structures eluci-
dated. Like SCB1, they also exhibit antibiotic stimulatory activity
in the producing strain.
The published and most widely used assays for detecting the
g-butyrolactone signaling molecules are bioassays that detect
antibiotic production (Hara and Beppu, 1982; Nihira et al.,
1988; Sato et al., 1989; Takano et al., 2000). For example, in
S. coelicolor, the SCB1 activity is determined by observing the
induced production of the pigmented antibiotics actinorhodin
and undecylprodigiosin (Takano et al., 2000). These bioassays,
however, can be tedious and in some cases difficult to use
because antibiotic production can be effected by indicator
lawn concentration, medium conditions, and cultivation time.
Furthermore, the g-butyrolactones are produced in minute
quantities and are difficult to isolate. Therefore, to study ligand
specificity to the receptor and to detect novel g-butyrolactones,
a simple yet sensitive and reproducible detection method is
necessary.
Previous studies revealed that the g-butyrolactone receptor,
ScbR, regulates the antibiotic production in S. coelicolor
through repressing the transcription of its own gene and that
of cpkO, a pathway-specific regulatory gene for the CPK
antibiotic biosynthesis gene cluster (Takano et al., 2005 and
Pawlik et al., 2007). The repression is abolished by the presence
of the g-butyrolactones, resulting in the transcription of the
target genes. Based on these findings, we have designed and
tested a new g-butyrolactone detection method using ScbR
as a sensor and the cpkO promoter coupled with a promo-
terless kanamycin resistance gene as a reporter to detect the
g-butyrolactones.960, September 25, 2009 ª2009 Elsevier Ltd All rights reserved 951
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g-Butyrolactone Reporter Assay in S. coelicolorSynthetic analogs of A-factor were analyzed for their biological
activity in Streptomyces griseus, the cognate host for A-factor
(Khokhlov, 1991). Similarly, Nihira and coworkers chemically
synthesized VB analogs (Nihira et al., 1988). These analogs
were tested for their ability to induce virginiamycin in the VB
cognate host, Streptomyces virginiae. These results from both
groups indicate the specificity of the VB or A-factor receptor
and the g-butyrolactone analogs. However, a systematic
analysis of chemically synthesized g-butyrolactone analogs to
the receptor protein, ScbR, from S. coelicolor has never been
carried out.
Therefore, to elucidate the specificity determinant, we have
synthesized 30 g-butyrolactone analogs including two newly
identified SCBs, SCB2 and SCB3. The biological activity of the
analogs was measured using the novel kanamycin bioassay
and affinity to ScbR was analyzed. Furthermore, we report the
possible application of this assay to detect g-butyrolactones
produced by actinomycetes.
RESULTS
The Isolation and Determination of New SCBs
from S. coelicolor
The structure of SCB1, a g-butyrolactone in S. coelicolor M145
with antibiotic stimulatory activity, has previously been deter-
mined (Takano et al., 2000). High-performance liquid chroma-
tography (HPLC) analysis indicates the presence of two further
Figure 1. The Types of the g-Butyrolactones and Their Examples
The three different types of the g-butyrolactones are indicated and their exam-
ples from SCB1. Chemical structures of SCB1 [()-SCB1 (2R,3R,10R)], its
isomers [(+)-SCB1 (2S,3S,10S)], VB type [()-SCB1 (2R,3R,10S)], VB type
[(+)-SCB1 (2S,3S,10R)], and the racemic A-factor are shown, and the names
of chemical structures are indicated below.952 Chemistry & Biology 16, 951–960, September 25, 2009 ª2009 Epeaks possessing antibiotic stimulatory activity in S. coelicolor
culture extracts, in addition to SCB1. These two minor peaks
were further analyzed using an antibiotic bioassay described
previously (Takano et al., 2000).
One HPLC peak fraction with a retention time (RT) very soon
after SCB1 was applied to a C18 reverse-phase column and
a bioactive peak with a RT of 24–25 min was detected (Figure 2A).
This sample was subjected to 400 MHz 1H-NMR for structure
elucidation and showed that the structure might be similar to
that of IM-2 C8, especially because a triplet Me signal at
0.89 ppm indicated the presence of one terminal Me on a linear
side chain, unlike the terminally branched side chain of SCB1
showing doublet Me signals (Figure S2). To further determine
the structure, chemically synthesized racemic IM-2 C8 (see
Experimental Procedures) was used for comparison of the C18
HPLC retention time, which suggested the structure to be
correct (Table 1). Furthermore, the bioassay of the synthetic
IM-2 C8 was active at similar concentrations to the natural
SCB1 (data not shown). This compound was named SCB2 and
the structure was determined as 2-(10-hydroxyoctyl)-3-hydroxy-
methylbutanolide (Figure 2B).
The other minor HPLC peak fraction was also applied onto
a C18 reverse-phase column and a bioactive peak with the RT
of 41–45 min was detected (data not shown). Assuming that
the lactone backbone is retained, the RT of 41–45 min is in
between those of IM-2 C8 (linear C8 side chain, 24–25 min)
and IM-2 C9 (linear C9 side chain, 54–56 min). Therefore the
structure of the compound with this RT could be IM-2 C9-sec
or IM-2 C9-i.
To further test this hypothesis, the two racemic IM-2 C9-sec
and IM-2 C9-i were chemically synthesized and the RT was deter-
mined on a reverse-phase HPLC. The chemically synthesized
racemic IM-2 C9-sec eluted at 44–46 min whereas the racemic
IM-2 C9-i eluted at 48–50 min (Table 1), suggesting that IM-2
C9-sec might be the structureof the secondpeak. Thiscompound
was named SCB3 and the structure was determined as 2-(10-
hydroxy-60-methyloctyl)-3-hydroxymethylbutanolide (Figure 2C).
To further confirm the structure of SCB2 and SCB3, mass
spectrometry (MS) and tandem MS were conducted using the
high-accuracy Orbitrap MS on the synthesized SCB1, SCB2,
SCB3, IM-2 C9-i and the ethyl acetate extract of supplemented
minimum medium solid (SMMS)-grown S. coelicolor M145.
The RT for the synthesized SCB1, SCB2, SCB3, and IM-2 C9-i
were 40.33, 41.12, 44.21, and 49.35/57.57, respectively (Table 1).
In the M145 ethyl acetate extract, RTs that correspond to the
mass equivalent to SCB1 [(M+H)+ 245.17], SCB2 [(M+H)+
245.17], and SCB3 [(M+H)+ 259.19] were similar but somewhat
earlier than the synthetic compounds (Table 1). This might be
due to the impurity in the M145 ethyl acetate extracts. However,
a mass corresponding to SCB3 [(M+H)+ 259.19] was not
detected at the same RT as IM-2 C9-i. This strongly confirms
the previous analysis and that the structure of SCB3 is indeed
2-(10-hydroxy-60-methyloctyl)-3-hydroxymethylbutanolide. The
MS and tandem MS spectra of the captured molecules in the
M145 ethyl acetate extract show high similarity to the synthe-
sized SCB1 and SCB2 [both have (M+H)+ 245.17] and also to
SCB3 [(M+H)+ 259.19] spectra that include the mono- or di-de-
hydrated structures of SCB1, SCB2, or SCB3, confirming the
production of these three butanolides in M145.lsevier Ltd All rights reserved
Figure 2. HPLC Profile and Antibiotic Bioassay for SCB2 and the Chemical Structure for SCB2 and SCB3
(A) HPLC profile of the M145 ethyl acetate extract is shown with the corresponding fractions analyzed for g-butyrolactones by antibiotic bioassay. Fraction 6 gave
bioactivity and was further purified and shown to be SCB2.
(B) The elucidated chemical structure of SCB2 [2-(10-hydroxyoctyl)-3-hydroxymethylbutanolide].
(C) The elucidated chemical structure of SCB3 [2-(10-hydroxy-60-methyloctyl)-3-hydroxymethylbutanolide].
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g-Butyrolactone Reporter Assay in S. coelicolorSynthesis of g-Butyrolactone Analogs for Use
in Structure-Activity Studies
The newly identified SCBs differ in the nature of the C-2 side
chain compared with the previously identified compound
SCB1. To determine the specificity of these ligands to the
receptor, further racemic analogs, IM-2 type, VB type, and
A-factor type were chemically synthesized with different side-
chain length and branching. Thirty different analogs can be
grouped into four types based on structure: (1) SCB1 isomers:
IM-2 type: ()-SCB1 [2R,3R,10R], (+)-SCB1 [2S,3S,10S], VB
type: ()-SCB1 [2R,3R,10S], (+)-SCB1 [2S,3S,10R]; (2) IM-2-
type analogs possessing a C-10-b-hydroxyl group with various
linear and branched C-2 side chains; (3) a VB-type series pos-
sessing a C-10-a-hydroxyl group with various linear and
branched C-2 side chains; and (4) A-factor type series possess-
ing a C-10-keto group. The chemical structures are shown in
Figures 1 and 4.
A New g-Butyrolactone Detection Assay Using
Kanamycin Resistance
To test the activity of the chemically synthesized analogs, the
previously published antibiotic bioassay based on the preco-
cious production of colored antibiotics could have been utilized
(Takano et al., 2000). However, this method is not always easy to
score because the production of the colored antibiotics can vary
with time, density of the inoculum used for the indicator lawn,
and batch of media used. Therefore, a new reporter systemChemistry & Biology 16, 951–9that is both easier to perform and gives a clearer measure of
g-butyrolactone activity was developed.
ScbR, the g-butyrolactone receptor, which has been shown
to be the only receptor that can recognize the g-butyrolactones
to promote antibiotic stimulatory activity, binds to its own
promoter region and to that of cpkO, a pathway-specific regula-
tory gene for the CPK cluster, and thereby represses the tran-
scription (Takano et al., 2005 and Pawlik et al., 2007). In the
Table 1. Retention Time of SCB1, SCB2 and SCB3 Chemically
Synthesized or Extracted from M145 Analyzed by HPLC or by
Nano-LC-Orbitrap MS
Retention Time (min)
Compound HPLC
(C18 RP Column)
Nano-LC-Orbitrap MS
Chemically synthesized
SCB1 23–24 40.33
SCB2 (IM-2 C8) 25–27 41.12
SCB3 (IM-2 C9-sec) 44–46 44.21
IM-2 C9-i 48–50 49.35/57.57
M145 ethyl acetate extract
SCB1 22–23 39.30
SCB2 (IM-2 C8) 24–25 40.20
SCB3 (IM-2 C9-sec) 40–48 43.9760, September 25, 2009 ª2009 Elsevier Ltd All rights reserved 953
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g-Butyrolactone Reporter Assay in S. coelicolorpresence of g-butyrolactones, ScbR binds to the g-butyrolac-
tones and relieves DNA binding, thus allowing the target genes
to be transcribed (Takano et al., 2005). Utilizing these proper-
ties of ScbR, a reporter system comprising a copy of scbR
controlled by its own promoter and the cpkO promoter complete
with the ScbR binding site fused to a promoterless kanamycin
resistance gene in the conjugative and integrating vector pIJ82
was constructed. This plasmid, named pTE134 (Figure S3),
was introduced into S. coelicolor LW16 (a scbA and scbR
double deletion mutant, see Experimental Procedures). LW16
does not produce any g-butyrolactones with antibiotic stimula-
tory activity as determined by the antibiotic bioassay (data not
shown). Therefore, in LW16, the ScbR resulting from pTE134
represses the cpkO promoter and the strain remains sensitive
to kanamycin. In the presence of g-butyrolactones, however,
ScbR repression is relieved and the strain becomes kanamycin
resistant. This method, therefore, was named the kanamycin
bioassay and can be used to detect g-butyrolactones that can
bind to ScbR.
A confluent lawn of S. coelicolor LW16::pTE134 spores was
plated onto Difco Nutrient Agar (DNAgar) plates containing
5 mg/ml kanamycin and spotted with synthesized SCB1 (6.25–
0.001 mg) and the M145 ethyl acetate extract (1 and 0.3 ml) at
the time of inoculation. After incubation, the kanamycin-resistant
colonies grew around the spot where the g-butyrolactones had
diffused (Figure 3). The same samples, the SCB1 and M145 ethyl
acetate extract, 0.25 and 0.05 ml and 1.0 and 0.3 ml, respectively,
were used for the antibiotic bioassay and also gave precocious
antibiotic production (Figure 3). To determine the lowest working
concentration detectable by the kanamycin bioassay, SCB1
Figure 3. The Kanamycin Bioassay and the
Antibiotic Bioassay Results of the M145
Ethyl Acetate Extract and the Chemically
Synthesized SCB1
The M145 ethyl acetate extract and the chemically
synthesized SCB1 were spotted onto a lawn
of LW16::pTE134 on DNAgar plates containing
5 mg/ml kanamycin, or on a confluent lawn of
M145. The amount of the extract and the SCB1
spotted is indicated above the plates. The plates
were incubated at 30C for 72 hr.
was added into the agar, instead of spot-
ting on top of the agar. This verified the
minimum concentration to be the same
as the antibiotic bioassay reported previ-
ously (Takano et al., 2000), 256 nM SCB1,
suggesting that both bioassays share the
same detection sensitivity toward SCB1.
The kanamycin bioassay was used
to compare the specificity of ScbR
toward known natural g-butyrolactones
(Table 2). ScbR shows the highest affinity
toward the naturally produced g-butyro-
lactones in its cognate host, SCB1 and
the racemic SCB3, with a 2-fold stronger
activity than the racemic SCB2. The
SCB1 used here is a pure stereochemical
compound compared with the racemic mixtures. The (+)- stereo-
chemical compound, which is present in the racemic mixture,
showed 250-fold less activity in the case of SCB1 (Table 2),
indicating that these stereochemical compounds for the other
g-butyrolactones might also have almost no activity and can
be disregarded. Therefore, the activity for the racemic mixtures
is approximately half for SCB2 (which possesses one chiral
carbon) and a quarter for SCB3 (which possesses two chiral
carbons) of what is observed. Taking this into account, the
activity can be recalculated to: SCB1 = 0.025, SCB2 = 0.025,
SCB3 = 0.006 mg. In conclusion, SCB3 has the highest affinity
toward ScbR, followed by SCB1 and SCB2 (Table 2 and
Figure S5).
The diameters of the halo detected with 6.25, 1.25, 0.25, 0.05,
and 0.025 mg SCB1 are 3.5, 3, 2.7, 2, and 1 cm, respectively
(Figure 3). This shows that the size of the growth halo increases
with increasing amounts of the natural SCB1. However, the rela-
tionship is not linear but shows a sigmoidal curve, and therefore
it is difficult to determine the concentration of samples by
analyzing the size of the growth halo.
The IM-2-type g-Butyrolactone Analog with a Long C-2
Side Chain Shows the Highest Specificity
in the Kanamycin Bioassay
The chemically synthesized structural analogs of SCBs were
tested for their binding specificity toward ScbR according to
the kanamycin bioassay results. The activity measurement taken
was the minimum amount of compound required for growth, as
determined by finding the lowest amount of compound capable
of inducing a visible halo of growth in the bioassay (Table 2).
954 Chemistry & Biology 16, 951–960, September 25, 2009 ª2009 Elsevier Ltd All rights reserved
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g-Butyrolactone Reporter Assay in S. coelicolorRacemic A-factor (6.25, 1.25, and 0.25 mg) was tested and the
minimum amount required for growth was 1.25 mg (Figure S4).
No growth was observed with racemic A-factor with a shorter
linear C-2 side chain, C4 or C5 (Table 2).
Twenty-seven chemically synthesized SCB1 isomers, racemic
IM-2-type, racemic VB-type g-butyrolactone analogs were also
tested using a range from 62.5 mg to 0.01 mg (Table 2, Figure 4).
Consistent with the previous results (Takano et al., 2000), among
the four pure SCB1 isomers ()-SCB1, (+)-SCB1, VB type
()-SCB1, and VB type (+)-SCB1, representing the four different
configurations of SCB1, ()-SCB1 showed the highest activity,
the minimum 0.025 mg being 250-fold lower than with the other
three analogs (Figure 1 and Figure S5). Asalso reported previously
(Takano et al., 2001), ScbR showed a higher specificity toward the
IM-2-type compounds possessing a 10-b-hydroxyl group, rather
than the VB type, which have a 10-a-hydroxyl group (Table 2).
The activity of the chemically synthesized racemic IM-2 type
analogs with varying lengths of the linear C-2 side chain was
tested. Those that possessed a length of 6 to 11 carbons had
the most specificity (Figure S6). No growth at all was detected
with the analogs possessing 5 or fewer carbons using up to
Table 2. Minimum Concentration of g-Butyrolactone Analogs
that Show Kanamycin Resistance
Analogues
IM-2 Type
(mg)
VB Type
(mg)
A-Factor
Type (mg)
SCB1
Isomers (mg)
C2 - NA NA NA
C3 - NA NA NA
C4 -
a NA - NA
C5 - - - NA
C6 12.5 -
b NA NA
C7 0.25 6.25
c NA NA
C8 0.05
d 1.25 NA NA
C9 0.25 0.25 NA NA
C10 1.25 1.25 NA NA
C11 6.25 - NA NA
C9-sec 1.25 12.5 NA NA
C9-i 0.25 0.25 NA NA
C9-sec 0.025e 1.25 NA NA
A-factor NA NA 1.25f NA
()-SCB1 NA NA NA 0.025g
(+)-SCB1 NA NA NA 6.25h
VB type (-)-SCB1 NA NA NA 6.25h
VB type (+)-SCB1 NA NA NA 6.25
All compounds are a racemic mixture apart from the four SCB1 isomers.
Minus sign indicates no growth halo on the plate (the highest used
amount is 31.25 mg, except for VB C6, where 62.5 mg was used); NA,
not applicable (this analog is unavailable). The superscript letters a–g
indicate the natural g-butyrolactones.
a IM-2.
b VB-C.
c VB-D.
d SCB2.
e SCB3.
f A-factor.
g SCB1.
h The growth halo was not clear.Chemistry & Biology 16, 951–931.25 mg compound. Because the maximum carbon chain length
tested was C11, the activity beyond this length is not known. The
most active among the IM-2-type analogs was the racemic
SCB2 (IM-2 C8, 0.05 mg), which possesses an 8 carbon C-2
side-chain length (Table 2).
Similarly, the specificity of the chemically synthesized racemic
VB type analogs with varying lengths of the linear C-2 side chain
was tested, and the 7 to 10 carbons had the highest specificity
(Figure S7). No growth was detected using 62.5 mg racemic VB
C6 (racemic VB-C, data not shown).
The different branching positions at the same C-2 side-chain
length within the IM-2-type and VB-type analogs were also
compared. The pure SCB1 [()-SCB1], possessing a C-60-methyl
group, is 50-fold more active than the racemic IM-2 C8-sec, pos-
sessing a C-50-methyl group, and 10-fold more active than the
racemic IM-2 C7, possessing a linear C-2 side chain. Further-
more, the racemic SCB3 (IM-2 C8-sec), possessing C-60-methyl
group, is 10-fold more active than the racemic IM-2 C9-i, pos-
sessing a C-70-methyl group, and 2-fold more active than the
racemic SCB2 (IM-2 C8), possessing a linear C-2 side chain
(Table 2 and Figure S8). However, the VB-type analogs with a
branched side chain did not show a significant difference (<6-
fold) as seen in the IM-2 type compounds (Table 2 and Figure S8).
Figure 4. The Chemical Structure of the Synthesized g-Butyrolac-
tone Analogs
The chemical skeletons of g-butyrolactones: (1) A-factor type, a C-10-keto
group; (2) VB type, a C-10-a-hydroxyl group; and (3) IM-2 type, a C-10-b-
hydroxyl group. Linear and branched alkyl side-chain substitutes (R) at C-2
along with their names are specified below.60, September 25, 2009 ª2009 Elsevier Ltd All rights reserved 955
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g-Butyrolactone Reporter Assay in S. coelicolorA summary of the minimum amount required for growth on
kanamycin for the chemically synthesized compounds is shown
in Table 2.
Identification of Two New Possible g-Butyrolactone-
Producing Actinomycetes Using the Kanamycin
Bioassay
The kanamycin bioassay was used to identify possible g-butyr-
olactone producers from among nine actinomycetes species
obtained from the Tu¨bingen strain collection (Table 3). These
nine species were grown on SMMS for 3 days (Figure S9), and
g-butyrolactones were isolated by ethyl acetate extraction (see
Experimental Procedures). Some species (Streptomyces anti-
bioticus ETH 6143, Streptomyces griseus ETH4289, Strepto-
myces tendae, and Nocardia brasiliensis) did not grow well on
SMMS or on SMMS supplemented with 5% yeast extract.
Nevertheless, all strains were isolated and tested. Extracts
from two of nine species, Streptomyces olivaceus ssp. atratus
and Streptomyces mediteranei, which are producers of narbo-
mycin and rifomycin, respectively, had an ability to induce
a growth halo in the bioassay (Figure S9), suggesting that these
two species produce compounds, most likely to be g-butyrolac-
tones, which have affinity toward ScbR.
DISCUSSION
Multiple g-Butyrolactones Produced in S. coelicolor
Two additional signaling molecules, SCB2 and SCB3, from
S. coelicolor were identified and both exhibit a similar lactone
structure to the previously identified compound SCB1, as well
Table 3. TheStreptomycesSpecies from theTu¨bingenCollection
that Were Tested for g-Butyrolactone Production
Strain Antibiotic
Growth
on Plates
Growth
Halo
Streptomyces antibioticus
ETH 6143 (Tu¨ 2)
Cinerubin O 
Streptomyces antibioticus
ETH 6677 (Tu¨ 4)
Angolamycin X 
Streptomyces olivaceus
ssp. Atratus (Tu¨ 5)
Narbomycin X +
Streptomyces griseus
ETH4289 (Tu¨ 19)
Streptomycin O 
Streptomyces tendae
ETH11313 (Tu¨ 21)
Carbomycin O 
Nocardia brasiliensis
ETH27413 (Tu¨ 69)
Ferrioxamin E O 
Streptosporangium roseum
ETH28349 (Tu¨ 74)
Unknown X 
Streptomyces mediteranei
(Tu¨ 75)
Rifomycin X +
Microellobosporia cinerae
ETH28583 (Tu¨ 76)
Unknown X 
Tu¨ 2–Tu¨ 76 indicate strain number of the Tu¨bingen strain collection. X
represents strains that grew well on the SMMS and SMMS supplemented
with yeast extract; O, strains that barely grew on the SMMS and SMMS
supplemented with yeast extract; , no growth halo on the plate; +,
growth halo on the plate.956 Chemistry & Biology 16, 951–960, September 25, 2009 ª2009 Eas the same IM-2 type stereospecificity. The difference in struc-
ture was the C-2 side-chain length with a linear C8 for SCB2 and
a branched C9 for SCB3. SCB2 did not correspond to any of the
six g-butyrolactones identified previously; however, because the
chirality of SCB3 was not assigned, there is a possibility that it
has the same structure as Acl1a (Figure S1; Anisova et al.,
1984). Both newly identified compounds induce precocious anti-
biotic production in an S. coelicolor bioassay, and the highest
affinity toward ScbR was shown by SCB3 followed by SCB1
and SCB2 as determined by the kanamycin bioassay.
The g-butyrolactones from S. coelicolor are synthesized by
ScbA, which is a protein also conserved in the A-factor and
VB-producing Streptomyces (Hsiao et al., 2007 and Kato et al.,
2007). The S. coelicolor scbA deletion mutant does not produce
any g-butyrolactones with antibiotic stimulatory activity (Takano
et al., 2001), indicating that SCB1, SCB2, and SCB3 all are
synthesized by ScbA. One possible explanation for the different
side-chain structures of the three signaling molecule might be
due to the precursors used in the biosynthesis, this suggests
a somewhat relaxed substrate specificity for ScbA. From the
proposed biosynthesis pathway of A-factor in Streptomyces
griseus, a dihydroxyacetone phosphate and a b-keto acid deriv-
ative is condensed by the ScbA homolog and further reduction
and dephosphorylation result in A-factor (Kato et al., 2007).
The b-keto acid derivatives might be provided either by a dedi-
cated biosynthesis pathway or by scavenging an intermediate
from fatty acid metabolism. We have extensively analyzed the
S. coelicolor genome and have been unable to identify a dedi-
cated biosynthesis pathway capable of providing the b-keto
acid derivatives. It is therefore seems likely that the fatty acid
metabolism intermediates are the precursors for SCB biosyn-
thesis. Streptomyces produce both linear and branched fatty
acids (Han et al., 1998), which correlate to the C-2 side-chain
differences observed in this work. The same hypothesis has
been suggested by Kato et al. (2007).
Interestingly, S. coelicolor is not the only multiple g-butyrolac-
tone-producing strain to have been reported. Five different
virginiae butanolides (VB-A to VB-E) were identified from Strep-
tomyces virginiae (Yamada et al., 1987 and Kondo et al., 1989),
and two active factors were isolated fromStreptomyces bikinien-
sis (Gra¨fe et al., 1983). In addition, g-butyrolactones from 11
Streptomyces species were analyzed by HPLC (Hashimoto
et al., 1992), and only 3 species produced a single g-butyrolac-
tone, whereas the others produced two to four different
compounds. It will be interesting to determine what the exact
roles of these different g-butyrolactones are in their producing
strains.
The New g-Butyrolactone Detection Reporter System
The kanamycin bioassay was successfully applied as a sensitive
g-butyrolactone detection tool in S. coelicolor. It utilizes the
cpkO promoter, which is tightly controlled by ScbR and is fused
to a kanamycin-resistance cassette along with the g-butyrolac-
tone receptor, ScbR, as a sensor. The high kanamycin sensitivity
in the absence of g-butyrolactone is due to the specific and
high affinity of ScbR to the cpkO promoter resulting in the tight
repression of the gene. Some spontaneous resistant mutants
do arise, especially with low concentrations of kanamycin (Fig-
ure S5). To obtain optimal sensitivity of the assay, kanamycinlsevier Ltd All rights reserved
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monitor the resistant growth without any background.
The kanamycin bioassay has the same minimum active
concentration for SCB1 as with the antibiotic bioassay (256 nM,
data not shown), which is reasonable considering that both
methods use ScbR as the sensor. However, when recognizing
the non-cognate g-butyrolactones, the kanamycin bioassay
was much more sensitive than the antibiotic bioassay. Only
50-fold higher concentration of A-factor, compared with SCB1,
was required to give activity with the kanamycin bioassay,
whereas the antibiotic bioassay required 100-fold higher con-
centration (Takano et al., 2000).
The kanamycin bioassay is also more sensitive than other
Streptomyces g-butyrolactone assays when detecting the non-
cognate signaling molecules. The A-factor bioassay required
3 3 103-fold higher concentration of VB (non-cognate signal)
than A-factor by the streptomycin cosynthesis method using
a streptomycin nonproducing mutant, S. griseus HH1 (Miyake
et al., 1989). A concentration of A-factor or IM-2 (non-cognate
signals) that was 1.7 3 104-fold higher than VB was required to
trigger virginiamycin production in a liquid culture of S. virginiae
(Hashimoto et al., 1992; Nihira et al., 1988), and a concentration
of VB-A (non-cognate signal) that was 8.33 104-fold higher than
IM-2 was required to induce the blue pigment production in
liquid cultures of Streptomyces lavendulae FRI-5 (Hashimoto
et al., 1992). This might reflect the higher sensitivity of the kana-
mycin bioassay because it is directly measuring the binding
affinity of the ligand to the receptor and not detecting antibiotic
production, which is the end product of the signaling cascade
and might have other unknown influences. However the higher
sensitivity can also lead to background kanamycin resistance
observed in some cases, which can be due to perturbations
and noise. In conclusion, this new assay is much clearer than
the antibiotic bioassay, is simple to use, and directly exhibits
the relationship between ScbR and the ligands.
Similar repressor-inducer reporter systems are available.
Tahlan and coworkers have developed a potential screening
method to detect ligands isolated from S. coelicolor that bind
to tetracycline-inducible repressor (tetR)-like regulators from
S. coelicolor using Escherichia coli as a host (Tahlan et al.,
2008). The tetR-operator regulation system from E. coli trans-
poson Tn10 has been widely used as a tool in many organisms
including Streptomyces (Stebbins et al., 2001; Rodrı´guez-Garcia
et al., 2005). However, this is the first reporter system using
a g-butyrolactone receptor to detect the signaling molecules in
Streptomyces.
ScbR Ligand Specificity
From our data, the chemical analogs with a shorter C-2 side-
chain length than 8 (for the IM-2 type) or 9 carbons (for the VB
type) resulted in a lower binding affinity than the SCBs and
must have at least 6 (for the IM-2 type) or 7 (for the VB type)
carbons and no more than 10 (for the VB type) carbons for the
C-2 side-chain length to bind to ScbR. We do not have ligands
with more than 11 carbons at the C-2 side chain to conclude
the limit of the longest C-2 side-chain length for the IM-2 type.
The IM-2-type analog with 9 carbons for the C-2 side-chain
length with branching at C-60 position showed the best affinity
than the branching at C-70 position and no branching, in thisChemistry & Biology 16, 951–9order. We have therefore shown for the first time, that the
branching at the C-60 position is the preferred ligand to bind to
ScbR. In conclusion, the g-butyrolactone structure with the
highest affinity to ScbR is as follows: (1) IM-2 type configuration,
(2) C-2 side-chain length of C7 or C8, (3) branching at the C-60
group.
Twenty-one synthetic analogs of A-factor with varying lengths
of either linear or branched C-2 side chains or different substi-
tutes at C-3 position were analyzed for their biological activity
in S. griseus, the cognate host for A-factor (Khokhlov, 1991).
None of these analogs gave significant activity compared with
A-factor except when the C-3 position was substituted for acyl-
ated products. The A-factor type analogs with one carbon longer
or shorter than C8 all with a methyl residue at the end of the chain
resulted in a 10-fold lower activity compared with A-factor
(Khokhlov, 1991). Similarly, Nihira and coworkers chemically
synthesized 41 VB analogs, varying the C-2 and C-3 stereo-
chemistry to include the A-factor and cis and trans VB type of
g-butyrolactones as described above, and also varying the C-2
linear side-chain length up to C10, and different substitutes for
the C-3 position (Nihira et al., 1988). These analogs were tested
for their ability to induce virginiamycin in the VB cognate host,
S. virginiae. The cis VB-type compounds with C7 and C8 linear
side chain was most active whereas the trans VB type
compounds with the equivalent side-chain length gave 12.5-
fold less activity. The C9 A-factor type compound was the only
A-factor analog to give the highest activity, which was 1250-
fold less compared with the cis VB-type C7 compound, thus
demonstrating the importance of the C-10 free hydroxy group.
For all three Streptomyces g-butyrolactone receptors that
were tested using synthetic analogs, the length of the C-2 side
chain is preferred to be C7 or C8. Furthermore, none exceeded
in their binding specificity toward the receptor than the naturally
produced g-butyrolactones. To obtain chemical ligands that
have better binding properties than the natural compounds,
other structural substitutes than that of the C-2 side-chain length
or branching will be interesting to test. Three-dimensional crys-
tallization analysis of the receptor with the various g-butyrolac-
tones might give valuable information on further binding specific-
ities and possible new structural substitutions.
Potential Application for the Kanamycin Bioassay
In the screening for possible new g-butyrolactone producers
(Table 3 and Figure S9), two of the nine tested strains from the
Tu¨bingen strain collection were able to produce compounds
that could be recognized by ScbR. These strains have not
been shown previously to produce any g-butyrolactones. The
extracts from the other strains did not show g-butyrolactone-
induced kanamycin-resistant growth, but this might be due to
the unsuitable growth conditions used for the preparation of
the extracts because in some cases the strains did not grow effi-
ciently. It is also possible that the extraction of the g-butyrolac-
tone was not at the appropriate time of growth, because these
compounds are known to be produced in a growth-dependent
manner (Takano, 2006). Therefore, optimizing the suitable
medium for growth and altering the timing for the extract prepa-
ration might assist in the detection of other g-butyrolactones
from different strains. This result, together with the higher sensi-
tivity toward the g-butyrolactones than the commonly used60, September 25, 2009 ª2009 Elsevier Ltd All rights reserved 957
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a powerful tool for large-scale screening of g-butyrolactone
producers.
SIGNIFICANCE
The significant conclusion from this work is the character-
ization of two further g-butyrolactones from S. coelicolor
and the identification of the g-butyrolactone receptor
(ScbR) specificity determinant by use of a novel small
signaling molecule reporter system analyzing both natural
and synthetic ligands. This is the first report where many
synthetic g-butyrolactone analogs were tested systemati-
cally to compare their binding specificity to ScbR. The
favored ligand consists of an IM-2-type b-hydroxyl group
on the C-10 position, with a long (7–10 carbons, with C8 rep-
resenting the best) C-2 side chain. Surprisingly, we have
been able to show for the first time the importance of
a methyl branch at the C-60 position of the C-2 side chain.
This preference was also confirmed because the newly
characterized g-butyrolactone, SCB3, follows the ScbR
ligand preference and has the highest affinity compared
with the two other cognate signaling molecules. Under-
standing the ligand specificity determinant will allow further
potential design of new compounds to either inhibit or to
promote antibiotic production by controlling ligand binding
to the g-butyrolactone receptor. The new sensitive reporter
system can be applied to detect g-butyrolactones that are
only produced in small quantities and can be difficult to
detect. We have demonstrated this use by identification of
two new commercial-antibiotic-producing Streptomyces
strains that most likely can synthesize g-butyrolactones
with affinity toward ScbR.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Conditions
Streptomyces strains M145, LW16 (this work), and DscbA (M751; Takano
et al., 2001) were manipulated as described elsewhere (Kieser et al., 2000).
E. coli JM101 was manipulated according to Sambrook et al. (1989). MS
agar (Kieser et al., 2000) was used to prepare spores and selection of excon-
jugants. SMM and SMMS agar (Takano et al., 2001) was used to isolate g-bu-
tyrolactones. SMMS agar (Takano et al., 2001) was used for the antibiotic
bioassay. DNAgar containing 5 mg/ml kanamycin was used for the kanamycin
bioassay. pGEM-T (Promega) was used for cloning polymerase chain reaction
(PCR) products. pIJ487 (Ward et al., 1986), pIJ6120 (Takano et al., 2001), and
pIJ82 (Hong et al., 2004) were used to construct the new reporter.
Purification and Structural Determination of g-Butyrolactones
The purification was conducted as reported previously (Takano et al., 2000).
The HPLC peak samples with precocious antibiotic production from these
purification was further analyzed by using a C18 reverse column (SHISEIDO
C18 capcellpak SG120/5 mm, 4.6 mm 3 250 mm) with a UV detector (Nippon
Bunko UVIDEC-100V) with elution solvent of 30% CH3CN/70% H2O/ 0.1%
TFA and flow rate of 1.0 ml/min.
1H-NMR analysis was done on a Nippon Denshi model JNM-GSX-400 spec-
trometer at 400 MHz in CDCl3 using CHCl3 dH 7.25 as an internal reference.
1H-NMR data for 2-(10-hydroxyoctyl)-3-hydroxymethylbutanolide: d 4.43
(1H, t, J = 8.8 Hz, H-4a), 4.02 (1H, m, H-10), 3.99 (1H, t, J = 8.8 Hz, H-4b),
3.76 (1H, dd, J = 5.6, 10.6 Hz, H-5a), 3.70 (1H, dd, J = 5.6, 10.6 Hz, H-5b),
2.78 (1H, m, H-3), 2.66 (1H, dd, J = 4.8, 9.2 Hz, H-2), 1.261.30 (10H, m,
H-30H-70), and 0.89 (3H, t, J = 6.5 Hz, H-80). One-dimensional 400 MHz958 Chemistry & Biology 16, 951–960, September 25, 2009 ª2009 E1H-NMR (Figure S2) indicated that the purified compound possessed a typical
2,3-disubstituted g-butyrolactone skeleton, as evident from the signals at
4.43, 4.02, 3.99, 3.76, 3.70, 2.78, and 2.66 ppm (see detailed explanation in
Figure S2).
Nano LC-Orbitrap MS Analysis of SCB1, SCB2, and SCB3
SMMS grown M145 ethyl acetate extracts resuspended in 100% MeOH was
analyzed using nano-liquid chromatography (LC) on-line coupled to an Orbi-
trap-MS (Thermo Scientific Corporation). Chemically synthesized SCB1,
SCB2, SCB3, and IM-2 C9-i (1 ng/ml) were used as reference standards and
SMMS and DscbA ethyl acetate extracts were injected as negative control.
The system was operated with electrospray ionization source in positive
mode. LC conditions were as follows: the column was a Dionex C18 column
(Acclaim PepMap100, C18, 3 mm, 75 mm i.d.3 15 cm); the mobile phase con-
sisted of A (H2O/0.1% formic acid) and B (acetonitrile/0.1% formic acid);
the gradient elution started with 20% B at 3 min, 95% B at 45 min, 95% B at
50 min, and 20% B at 55 min and was then kept at 20% B until 60 min, flow
rate 0.200 ml/min, MS mass detection range 150–500 Da. One microliter of
the reference standards and 5 ml ethyl acetate extracts were injected. Analysis
was done by using Xcalibur software (Thermo Fisher Scientific).
Isolation of g-Butyrolactones and the Antibiotic Bioassay
g-Butyrolactone isolation from liquid or solid cultures and the antibiotic
bioassay were followed as described previously (Takano et al., 2000).
Construction of scbA and scbR Double Deletion Mutant
To construct the scbA scbR double deletion mutant, the disruption cassette,
aac(3)IV-oriT, from the plasmid pIJ773 (Gust et al., 2003) was amplified by
the primers, RB4F and RB4R (Supplemental Data) and the resulting PCR
product was cloned into the cosmid AH10 and then introduced into S. coeli-
color according to the REDIRECT procedure (Gust et al., 2003). M145
recombinants were screened for apramycin resistance and the deletion was
confirmed by PCR using the primers DDAR2 and scbA sec2 (Supplemental
Data), and by Southern analysis (data not shown). The mutant was named
S. coelicolor LW16.
Construction of the Kanamycin Assay Strain
The promoterless kanamycin gene was PCR amplified from the plasmid pIJ487
by using the primers Tnneo1 and neo2 (Supplemental Data). The PCR fragment
was cloned into pGEM-T vector (Promega) to obtain pTE130. The EcoRI
digested fragment from pTE130 was subcloned into the EcoRI site of
pIJ6120 (which contains an intact scbR and its own promoter region) in the
orientation so that the start codon of the promoterless kanamycin gene is
flanked by the SacI site (Takano et al., 2005), to create pTE131. A 146 bp
PCR fragment, corresponding to 25 to +34 from the starting site, containing
a cpkO promoter and the ScbR binding site region (Takano et al., 2005) was
amplified by using the primers pkasO1 and pkasO2 (Supplemental Data), which
contain an SacI restriction site at the 50 end of each primer, and S. coelicolor
M145 genomic DNA was used as template. After digestion with SacI, the
137 bp PCR fragment was ligated intoSacI-digested pTE131 with the promoter
orientated to direct transcription toward the promoterless kanamycin gene to
obtain pTE133. A 2.22 kb BglII fragment from pTE133 was then subcloned
into a BamHI site of pIJ82, an integrating vector, to yield pTE134. The relative
orientation of the scbR and the cpkO promoter with the neo was confirmed
by PCR with the primers pkasO1, pkasO2, scbRrt2, and neo2. pTE134 DNA
was sequenced by MWG Biotech AG (data not shown).
pTE134 was introduced into the methylation-deficient E. coli strain ET12567
containing the RP4 derivative pUZ8002 (Flett et al., 1997), and transferred to
S. coelicolor LW16 by conjugation (Flett et al., 1997). Single-crossover excon-
jugants were selected on MS containing hygromycin and nalidixic acid, to
obtain transconjugants LW16::pTE134. The genomic DNA was isolated and
plasmid integration was confirmed by PCR with the primers JGattB1-fwd
and JGattPint-rev (Supplemental Data), which gave an amplified product of
0.8 kb corresponding to the inserted region (data not shown).
The Kanamycin Bioassay
Chemically synthesized autoregulator analogs or methanol-extracted g-butyr-
olactones from S. coelicolor M145, DscbA, and various Streptomyces specieslsevier Ltd All rights reserved
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plated on DNAgar supplemented with kanamycin at a final concentration of
5 mg/ml and then incubated at 30C for 3 days. Methanol was used as a nega-
tive control. For detailed protocol see Hsiao et al. (2009). To determine the
detection range of the kanamycin bioassay, 62.5 mg to 0.01 mg autoregulator
analogs was tested.
Chemical Synthesis of Autoregulator Analogs
A-factor type analogs (Figure 4) containing a C-10 keto group with various alkyl
side chains at C-2 were synthesized as previously described (Nihira et al.,
1988) by reacting 3-(trimethylsilyoxymethyl)butanolide with a suitable alkyl
chloride.
Virginiae butanolide (VB) type analogs (Figure 4) and IM-2 type analogs
(Figure 4) with various linear alkyl side chains at C-2 were synthesized as
described before (Kim et al., 1989) by reacting 3-(trimethylsilyoxymethyl)buta-
nolide with a suitable linear aldehyde by Aldol condensation.
For the synthesis of VB-type and IM-2 type analogs containing 10-hydroxy-
70-methyloctyl, 10-hydroxy-60-methyloctyl, or 10-hydroxy-50-methylheptyl side
chain (VB C9-i, IM-2 C9-i, VB C9 s, IM-2 C9 s, VB C8 s, or IM-2 C8 s), correspond-
ing branched-chain carboxylic acids (7-methyloctanoic acid, and 6-methyoc-
tanoic acid) were first synthesized from 5-bromovaleric acid and isobutyl
bromide or sec-butyl bromide, respectively, using modified Grignard reaction
in the presence of dilithium tetrachlorocuprate (Baer and Carney, 1976). Alkyl
chloride was prepared from the branched-chain carboxylic acid and was used
to synthesize the corresponding A-factor-type analogs, and reduction with
NaBH4 gave corresponding VB-type and IM-2-type analogs (Figure 4).
SCB1 and its isomers (Figure 1), which contain 10-hydroxy-70-methylheptyl
side chain at C-2, were synthesized as previously described (Takano et al.,
2000).
The synthesized compounds were purified by C18 HPLC and the structure
confirmed by 1H-NMR analysis on a Nippon Denshi model JNM-GSX-400
spectrometer at 400 MHz in CDCl3 using CHCl3 dH 7.25 as an internal
reference.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and nine
figures and can be found with the article online at http://www.cell.com/
chemistry-biology/supplemental/S1074-5521(09)00279-8.
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